From the multivariate analysis, which included established clinical and histomorphological factors and YB-1 staining status, translocation of YB-1 protein into the nucleus of tumour cells at the IF emerged as a statistically independent prognostic biomarker, in addition to lymph node involvement. The gene discussed is YBX1; the disease is neoplasm.